Results 141 to 150 of about 30,009 (273)
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Editorial: Neuropsychological testing: from psychometrics to clinical neuropsychology. [PDF]
Facchin A, Cavicchiolo E, Chan E.
europepmc +1 more source
Plasma biomarkers for Alzheimer's and related dementias: A review and outlook for clinical neuropsychology. [PDF]
Dark HE, Duggan MR, Walker KA.
europepmc +1 more source
A guide to neuromodulation in drug‐resistant epilepsy
Abstract Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good resective surgical ...
Prachi Parikh +10 more
wiley +1 more source
Predicting post‐surgical visuospatial memory performance in people with drug‐resistant epilepsy
Abstract Objective Although verbal memory decline has been consistently reported following surgery for temporal lobe epilepsy, especially when surgery is performed in the language‐dominant hemisphere and targets mesial temporal structures, the relation between the location and the hemisphere of surgery on visuospatial memory, as well as the factors ...
Emma Colucci +7 more
wiley +1 more source
Abstract This seminar addresses the complexity of the management of epilepsy in adults with intellectual development disorders (IDD), advocating holistic and multidisciplinary care aligned with the learning objectives of the International League Against Epilepsy. Epilepsy is significantly more prevalent in people with IDD, presenting unique diagnostic,
Elena Fonseca +10 more
wiley +1 more source
Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology [PDF]
Gérard Emilien +3 more
openalex +1 more source
Civil Capacities in Clinical Neuropsychology: Research Findings in Clinical Neuropsychology [PDF]
M. R. Basso, D. Combs
openaire +1 more source
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin +7 more
wiley +1 more source

